Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9236643 | Clinical Immunology | 2005 | 6 Pages |
Abstract
Classic T lymphocyte cytotoxicity is mediated through the T cell receptor (TCR). Defects in TCR signal transduction and cytolytic activity have been reported in tumor infiltrating T lymphocytes. We hypothesized that impaired cytotoxicity occurs in peripheral blood T cells from renal cell carcinoma (RCC) that can be reversed by exposure to rhIL-2. Peripheral blood mononuclear cells (PBMC) from 29 RCC patients and 29 healthy volunteers were isolated and cultured in the absence or presence of 10 IU/ml rhIL-2. A redirected cytotoxicity assay that requires TCR signal transduction was used with chromium-labeled P815 target cells, effector PBMC and anti-CD3 antibody. Target cell lysis was measured in “lytic units” (LU). Mean LU from RCC patients was lower than that of healthy volunteers (105.8 LU vs. 194.6 LU, PÂ =Â 0.025). Exposure to rhIL-2 increased T cell-mediated lysis in both groups. Disruption of T cell cytotoxicity in RCC patients can be overcome by exposure to rhIL-2.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Todd S. Crocenzi, Christopher P.G. Tretter, Thomas Schwaab, Alan R. Schned, John A. Heaney, Bernard F. Cole, Jan L. Fisher, Marc S. Ernstoff,